COMMUNIQUÉS West-GlobeNewswire

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
29/12/2025
CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, [...]
Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet
29/12/2025
Company to Continue Advancing Product Development and Regulatory Progress of Its Core Medical Pipeline Raanana, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the [...]
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
29/12/2025
ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal [...]
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
29/12/2025
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection [...]
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
29/12/2025
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the [...]
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
29/12/2025
STAFFORD, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
29/12/2025
— NDA supported by results from a Phase II registration trial in China — — Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in comparison — HONG KONG and [...]
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
29/12/2025
PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated [...]
BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs
28/12/2025
An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for 2026 Detroit, MI, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes [...]
Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options
28/12/2025
Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into 2026. IRVINE, Dec [...]
Best SARM for Bulking and Muscle Growth 2026 – A Guide to SARMs Stacks for Cutting, Strength, Endurance & Recovery" SARMs Launched By Crazy Bulk
27/12/2025
The Best SARMS for Strength, Cutting, Muscle Growth, Body Building & Recovery - A Guide to SARMs: Definition, Side Effects and Dangers New York City,, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Crazy Bulk Brands has unveiled [...]
How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ
27/12/2025
Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details – Best Weight Loss Supplement New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Maintaining a healthy weight is a multifaceted issue that [...]
Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand
27/12/2025
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before Choosing a Telehealth NAD+ Provider in 2026 ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) -- [...]
Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
27/12/2025
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to Regulations SAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings renewed interest in [...]
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts
27/12/2025
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage Resolution Reshapes Weight Loss Medication Landscape Bluffdale, Dec. 26, 2025 (GLOBE [...]
Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026
27/12/2025
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle-free formats. SCOTTSDALE, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for [...]
Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd
27/12/2025
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements to boost metabolism, control appetite & burn fat. New York City, NY, Dec. 26, 2025 (GLOBE NEWSWIRE) -- [...]
Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
27/12/2025
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded Options Alongside New FDA-Approved Oral Pathway Los Angeles, Dec. 26, 2025 (GLOBE NEWSWIRE) -- [...]
MEDIROM Partners with World
26/12/2025
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, [...]

Pages